Clinical Trial Update: Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

The study evaluated the glycemic effects of Colesevelam HCl (Welchol) in adults with Type 2 diabetes; results from Phase 2 and Phase 3 were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Welchol (colesevelam hydrochloride)

Snippet

Sponsor: HealthPartners Institute | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-06-17